mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.8 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
-0.0093 |
0.8 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.8 |
mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0089 |
0.8 |
mRNA |
Panobinostat |
CTRPv2 |
pan-cancer |
AAC |
-0.0083 |
0.8 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0091 |
0.8 |
mRNA |
SID 26681509 |
CTRPv2 |
pan-cancer |
AAC |
0.0095 |
0.8 |
mRNA |
RITA |
CTRPv2 |
pan-cancer |
AAC |
-0.0086 |
0.8 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |
mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
-0.013 |
0.8 |